Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W51270299
